…formidable challenge in contemporary cardiovascular medicine. As a primary driver of sudden cardiac death (SCD) and a major cause of morbidity in patients with structural…
25 träffar
…formidable challenge in contemporary cardiovascular medicine. As a primary driver of sudden cardiac death (SCD) and a major cause of morbidity in patients with structural…
…adverse environmental exposures are associated with continued or resumed smoking after the acute event and warrant particular attention. Cardiovascular benefits of cessation The principal benefits…
…90% of thrombi in non valvular AF originate within this specific anatomical cul de sac [19] . Concurrently, the atrial myocardium undergoes structural remodeling driven by…
…both as an independent cardiovascular risk factor and as a driver of hypertension, diabetes, dyslipidaemia and systemic inflammation. It is also associated with respiratory disorders…
…of increasing coronary blood flow. In circumstances with non shockable rhythm or with prolonged periods of VF (fine VF resistant to defibrillations), the purpose of…
…or bipolar mode of pacing (Figure 3). In bipolar pacing, the voltage difference is established at the lead tip, between the anode and cathode. With…
…Return of Spontaneous Circulation (ROSC) : Return of mechanical cardiac function resulting in circulation with pulse. Coronary perfusion pressure (CPP) : The pressure that drives blood flow…
…progressive, and highly complex lipid driven inflammatory disease of the arterial intima that serves as the fundamental pathophysiological substrate for acute coronary syndromes (ACS), including…
…for the majority of cases, and the great majority of objects can be removed in general practice or in the emergency department with simple equipment…
… the presence of spontaneous atrial or ventricular activity should inhibit pacing in the chamber with activity. However, sensing of spontaneous atrial activity (P waves) without…
…LVEF). The majority of all clinical trials, epidemiological studies and mechanistic studies have been carried out in HFREF (heart failure with reduced ejection fraction) . Thus…
…LVEF). The majority of all clinical trials, epidemiological studies and mechanistic studies have been carried out in HFREF (heart failure with reduced ejection fraction) . Thus…
…is not uniformly present. The proportion of painless or silent STEMIs is greater in patients with diabetes mellitus and increases with age. STEMI may present…
…In a large network meta analysis, 3 month DAPT, but not 6 month DAPT, was associated with higher rates of myocardial infarction or stent thrombosis…
…cTn) values in the setting of acute or chronic heart failure are often better categorised as myocardial injury. Clinical Presentation and Symptoms Patients with Type…
…the Get With The Guidelines Heart Failure (GWTG HF) and the SWEDEHEART registries, demonstrate that while the incidence of HFrEF has stabilized or slightly declined…
…and/or fall of high sensitivity cardiac troponin (hs cTn), with at least one value above the 99th percentile upper reference limit (URL) in the…
…Therapies : Consideration of endomyocardial biopsy or anti inflammatory therapies may be warranted in specific clinical contexts [4]. Reduction of Sympathetic Drive Modulating autonomic tone is…
…bidirectional. AF with a rapid ventricular response may precipitate or aggravate haemodynamic decompensation, whereas acute illness and increased sympathetic drive may promote AF. In DHF…
…Symptoms In the management of heart failure, digoxin improves hemodynamics without increasing heart rate or decreasing blood pressure, making it a consideration for patients with…
…in stent disease is driven predominantly by tissue accumulation within the stented segment rather than by negative remodelling. Pathophysiology Neointimal hyperplasia The principal mechanism of…
…to capture these specific pathological drivers. 5 Physiological Mechanisms of Cardioprotection: Direct vs. Weight Mediated The profound cardiovascular benefits observed with incretin based therapies cannot…
…diffuse microvascular dysfunction, or flow limiting epicardial stenoses), is the predominant cause, accounting for approximately 60% of HFrEF cases in Western populations [14] . Non ischemic…
…vascular territory involved and may include manifestations of coronary, cerebral or peripheral arterial disease, although the source material does not specify symptom patterns in detail…
…peptides. HF with mildly reduced ejection fraction (HFmrEF) is defined by symptoms and/or signs of HF with LVEF 41–49%. In this group, structural…